Skip to main content

Why ePharmacy Customers will Reach 1 Billion

Healthcare, and closely related pharmacy services, are due for disruption. Online pharmacies can deliver pharmaceuticals direct to customers, potentially changing the way they compare prices. These patients can now order their medications from registered pharmacists via the Internet.

Patients can simply upload a copy of their prescriptions. Each medication request is controlled by registered pharmacists who direct them to the pharmacy warehouse in the region of the patient.

Patients can access an ePharmacy through a software app, or through a website. Each ePharmacy will provide a variety of different services -- including online consultations, repeat prescriptions, lab tests, and over-the-counter (OTC) medication.

Global ePharmacy Market Development

According to the latest worldwide market study by Juniper Research, the number of ePharmacy users will reach 1 billion globally by 2027 -- that's increasing from 795 million in 2022, a growth of 28 percent.

This increase is partly due to adoption resulting from the COVID-19 pandemic, where consumers were unable to leave their homes and turned to ePharmacies for their medications.

Growth will continue, as vendors focus on retaining and expanding their customer bases by refining the efficiency and simplicity, and lower-cost business operating model that ePharmacy provides.

Juniper predicts that people will continue to use ePharmacies as they reap the benefits of medication affordability, and a wider choice compared to traditional retail pharmacies.

Furthermore, ePharmacy growth will be sustained by simplifying the online process. This is achieved by widespread acceptance of ePrescriptions -- eliminating legacy paper copies of prescriptions.

"ePharmacy vendors have the ability to further simplify the process through the use of solutions, including consumers receiving their prescribed medication, sorted into daily pouches containing information regarding dosage, date and time to be taken," said Cara Malone, research analyst at Juniper Research.

Outlook for Global ePharmacy Applications Growth

Juniper analysts anticipate that ePharmacy services will continue to be predominantly utilized for OTC medication. Moreover, OTC transactions will reach 8.9 billion globally in 2027 -- accounting for 64 percent of the total global transaction value.

This is compared to 5 billion medication prescription transactions globally in the same year. That said, I anticipate that ePrescriptions may be impacted from inertia created by the legacy industry players resisting change due to fears that their profitable business model is disrupted.

According to the Juniper assessment, in order to allay these concerns and offset the abundance of new ePharmacies, real-time tracking and stronger regulations should be priorities to secure future growth.

Popular posts from this blog

Why GenAI Investment will Double in 2024

In 2024, every business can be a technology-driven business. The quest for business technology leadership skills, and digital transformation, will gain new momentum as more organizations seek ways to drive net-new digital growth. Large enterprises will invest more than $19.4 billion worldwide in Generative Artificial Intelligence (GenAI) solutions in 2023, according to the latest market study by International Data Corporation (IDC). This spending, which includes GenAI software as well as related infrastructure hardware and IT or business services, is expected to more than double in 2024 and reach $151.1 billion in 2027 -- that's with a compound annual growth rate (CAGR) of 86.1 percent over the 2023-2027 forecast period. Artificial Intelligence Market Development Despite the recent IT headwinds in 2023, business leaders accelerated their exploration of GenAI solutions to help boost their digital business transformation. "In 2024, the shift to AI everywhere will enter a critic